Home LiteratureArticle Details
PMID: 10493747 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.

Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW

Abstract

Oligodendrocytes (OLs) extend processes to contact axons as a prerequisite step in myelin formation. As the OL processes migrate toward their axonal targets, they modify adhesion to their substrate, an event that may be regulated by matrix metalloproteinases (MMPs). In the mouse optic nerve, MMP-9/gelatinase B increases during myelin formation. Although tissue inhibitor of metalloproteinase (TIMP)-3 also increases in parallel, the developing optic nerve has focally active MMPs demonstrable by in situ zymography. The distribution of proteolytic activity is similar to that of myelin basic protein, a marker of myelin formation. OLs in culture secrete MMP-9 and express active cell-associated metalloproteinases at the growing tips of their processes. TIMP-1 and a function-perturbing anti-MMP-9 antibody attenuate outgrowth of processes by OLs, indicating a requirement for MMP-9 in process outgrowth. Process reformation is retarded significantly in OLs cultured from MMP-9 null mice, as compared with controls, providing genetic evidence that MMP-9 is necessary for process outgrowth. These data show that MMP-9 facilitates process outgrowth by OLs in vivo and in culture.

MeSH Terms
Adult Aging/physiology Animals Axons/physiology Brain/enzymology Cells, Cultured Collagenases/deficiency,genetics,metabolism Gelatinases/genetics,metabolism Gene Expression Regulation, Developmental Gene Expression Regulation, Enzymologic Humans Matrix Metalloproteinase 2 Matrix Metalloproteinase 9 Metalloendopeptidases/genetics,metabolism Mice Mice, Knockout Myelin Sheath/physiology Oligodendroglia/enzymology,physiology,ultrastructure Optic Nerve/enzymology,growth & development,physiology
Chemicals
Collagenases Gelatinases Metalloendopeptidases Matrix Metalloproteinase 2 Matrix Metalloproteinase 9
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Oh L Y
Departments of Oncology and Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada T2N 4N1.
Larsen P H
Krekoski C A
Edwards D R
Donovan F
Werb Z
Yong V W
References (59)
59 references, click to expand
  1. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice.
    Endocrinology. 1997 Nov;138(11):4902-11 PMID: 9348221
  2. NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells.
    Neuron. 1989 Jun;2(6):1587-96 PMID: 2560648
  3. Degradation of underlying extracellular matrix by sensory neurons during neurite outgrowth.
    Neuron. 1990 Apr;4(4):633-42 PMID: 2182079
  4. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.
    J Neurosci Res. 1989 Dec;24(4):548-57 PMID: 2600978
  5. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
    Neuropathol Appl Neurobiol. 1997 Oct;23(5):406-15 PMID: 9364466
  6. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790.
    Inflamm Res. 1995 Aug;44(8):345-9 PMID: 8581522
  7. Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform alpha as a mediator of process outgrowth.
    J Neurosci Res. 1994 Sep 1;39(1):83-96 PMID: 7807594
  8. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
    J Neuropathol Exp Neurol. 1996 Mar;55(3):300-9 PMID: 8786388
  9. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions.
    J Neuropathol Exp Neurol. 1992 Jan;51(1):40-6 PMID: 1740673
  10. Evolving concepts and issues in remyelination.
    Dev Neurosci. 1989;11(2):140-8 PMID: 2663422
  11. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.
    Glia. 1998 Jan;22(1):53-63 PMID: 9436787
  12. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
    J Neurochem. 1997 Sep;69(3):939-46 PMID: 9282915
  13. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution.
    J Neuropathol Exp Neurol. 1996 Dec;55(12):1194-204 PMID: 8957442
  14. Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain.
    Neurosci Lett. 1992 Feb 3;135(2):219-23 PMID: 1625798
  15. Multiple sclerosis: remyelination in acute lesions.
    J Neuropathol Exp Neurol. 1993 May;52(3):199-204 PMID: 7684075
  16. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.
    J Cell Biol. 1999 Jan 25;144(2):373-84 PMID: 9922462
  17. Activation mechanisms of matrix metalloproteinases.
    Biol Chem. 1997 Mar-Apr;378(3-4):151-60 PMID: 9165065
  18. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination.
    Neuron. 1996 Oct;17(4):607-15 PMID: 8893019
  19. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
    Ann Neurol. 1998 Apr;43(4):427-34 PMID: 9546322
  20. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.
    Ann Neurol. 1996 Dec;40(6):853-63 PMID: 9007090
  21. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix.
    Glia. 1996 Jul;17(3):237-53 PMID: 8840165
  22. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway.
    Neuron. 1998 Oct;21(4):813-25 PMID: 9808467
  23. Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin.
    Eur J Neurosci. 1997 Jan;9(1):151-62 PMID: 9042579
  24. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor.
    Exp Cell Res. 1994 Feb;210(2):243-52 PMID: 8299723
  25. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
    J Clin Invest. 1994 Dec;94(6):2177-82 PMID: 7989572
  26. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system.
    Dev Biol. 1981 Apr 30;83(2):311-27 PMID: 6786942
  27. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions.
    Neuron. 1995 Jan;14(1):29-41 PMID: 7826639
  28. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization.
    Brain Res Dev Brain Res. 1995 Aug 28;88(1):37-52 PMID: 7493406
  29. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Cancer Res. 1998 Aug 15;58(16):3743-50 PMID: 9721888
  30. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.
    Cell. 1998 May 1;93(3):411-22 PMID: 9590175
  31. FGF-2 converts mature oligodendrocytes to a novel phenotype.
    J Neurosci Res. 1997 Oct 15;50(2):215-28 PMID: 9373031
  32. Age-dependent decrease of process formation by cultured oligodendrocytes is augmented by protein kinase C stimulation.
    J Neurosci Res. 1991 May;29(1):87-99 PMID: 1886171
  33. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Am J Pathol. 1998 Dec;153(6):1895-902 PMID: 9846979
  34. The promoting effects of bFGF and astrocyte extracellular matrix on process outgrowth by adult human oligodendrocytes are mediated by protein kinase C.
    Brain Res. 1997 May 23;757(2):236-44 PMID: 9200752
  35. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.
    Lab Invest. 1992 Jul;67(1):88-99 PMID: 1625450
  36. Immunocytochemical localization by electron microscopy of 2'3'-cyclic nucleotide 3'-phosphodiesterase in developing oligodendrocytes of normal and mutant brain.
    J Neurosci. 1988 Aug;8(8):3057-66 PMID: 2842470
  37. Matrix metalloproteinases and diseases of the CNS.
    Trends Neurosci. 1998 Feb;21(2):75-80 PMID: 9498303
  38. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan.
    J Neurosci. 1998 Jul 15;18(14):5203-11 PMID: 9651203
  39. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene.
    J Neurosci. 1992 Dec;12(12):4890-7 PMID: 1281497
  40. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia.
    Cancer Res. 1993 Jul 1;53(13):3159-64 PMID: 8391388
  41. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth.
    Trends Neurosci. 1988 Dec;11(12):541-4 PMID: 2471310
  42. Attenuation of astroglial reactivity by interleukin-10.
    J Neurosci. 1996 May 1;16(9):2945-55 PMID: 8622125
  43. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
    Acta Neuropathol. 1997 Dec;94(6):590-8 PMID: 9444361
  44. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
    Cell. 1996 May 31;85(5):683-93 PMID: 8646777
  45. Remyelination in the human central nervous system.
    J Neuropathol Exp Neurol. 1989 Sep;48(5):507-18 PMID: 2769306
  46. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?
    Matrix Biol. 1997 Mar;15(8-9):511-8 PMID: 9138283
  47. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
    Genes Dev. 1999 Jan 1;13(1):35-48 PMID: 9887098
  48. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.
    J Neuroimmunol. 1996 Sep;69(1-2):141-9 PMID: 8823386
  49. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Lab Invest. 1989 Nov;61(5):489-503 PMID: 2811298
  50. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
    Ann Neurol. 1998 Jul;44(1):35-46 PMID: 9667591
  51. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally.
    EMBO J. 1995 Apr 18;14(8):1590-8 PMID: 7737111
  52. Two proliferative stages of the oligodendrocyte lineage (A2B5+O4- and O4+GalC-) under different mitogenic control.
    Neuron. 1990 Nov;5(5):615-25 PMID: 2223090
  53. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts.
    J Cell Biol. 1991 Apr;113(2):437-49 PMID: 1849141
  54. The family of matrix metalloproteinases.
    Ann N Y Acad Sci. 1994 Sep 6;732:11-21 PMID: 7978784
  55. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells.
    Cancer Res. 1994 Nov 1;54(21):5702-10 PMID: 7923219
  56. Inhibition of retinal growth cone activity by specific metalloproteinase inhibitors in vitro.
    Dev Dyn. 1994 May;200(1):79-88 PMID: 8081016
  57. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues.
    J Biol Chem. 1994 Mar 25;269(12):9352-60 PMID: 8132674
  58. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase.
    Brain Res. 1992 Apr 3;576(2):203-7 PMID: 1381261
  59. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion.
    Am J Pathol. 1998 Jan;152(1):251-9 PMID: 9422542
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
1999-10-01
Pages
8464-75
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6783003
Subset
IM
Grants
NICHD NIH HHS · HD26732 · United States
NIEHS NIH HHS · T32 ES07106 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com